Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Vancomycin 100 MG/ML Injectable Solution

Known as: VANCOMYCIN HYDROCHLORIDE 10 g INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, vancomycin (as vancomycin hydrochloride) 100 MG/ML Injectable Solution, VANCOMYCIN HYDROCHLORIDE 10 g in 100 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Vancomycin Hydrochloride] 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
In der neurologisch-neurochirurgischen Fruh­rehabilitation stellen multiresistente Erreger ein erhebliches Problem dar, auch wenn… Expand
Is this relevant?
2013
2013
STUDY OBJECTIVE To compare the likelihood of alternative vancomycin dosing strategies based on weight, height, or body surface… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2013
2013
Vancomycin-intermediate Staphylococcus aureus (VISA) infections are an emerging problem and antibiotic options are limited. We… Expand
Is this relevant?
2010
2010
Methicillin-resistant Staphylococcus aureus (MRSA) infections are increasingly being reported among cystic fibrosis (CF… Expand
  • table 2
Is this relevant?
2009
2009
Zusammenfassung In den letzten Jahrzehnten wird zunehmend uber eine Haufung von Patienten mit dem Nachweis von so genannten… Expand
Is this relevant?
2008
2008
A vancomycin-intermediate Staphylococcus aureus (VISA) isolated from the blood of a 46-year-old patient with endocarditis was… Expand
Is this relevant?
2002
2002
In order to optimize the dosage regimen of vancomycin in neonates, we investigated the population pharmacokinetics and the… Expand
Is this relevant?
1990
1990
SummaryWe assessed the efficacy of a piperacillin (3×4 g/d) and netilmicin (5 mg/kg/d) combination therapy for infections in… Expand
Is this relevant?
1988
1988
 
Is this relevant?